Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2007
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signatureItziar Salaverria, Andreas Zettl, Sílvia Beà, et al.
Blood|April 28, 2010
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profilingElena M Hartmann, Elias Campo, George Wright, et al.
Cancer Cell|August 19, 2007
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myelomaChristina M Annunziata, R Eric Davis, Yulia Demchenko, et al.
Cancer Cell|November 16, 2016
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell NeoplasmMichele Ceribelli, Zhiying Esther Hou, Priscilla N Kelly, et al.
British Journal of Haematology|February 6, 2007
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanismsAndrew J Davies, Andreas Rosenwald, George Wright, et al.
Blood|May 28, 2009
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterationsEllen Leich, Itziar Salaverria, Silvia Bea, et al.
The American Journal of Surgical Pathology|July 3, 2015
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression ProfilingJi Yuan, George Wright, Andreas Rosenwald, et al.
Blood Advances|September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphomaColleen A Ramsower, George Wright, Hongli Li, et al.
Cancer Cell|June 16, 2012
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphomaYibin Yang, Arthur L Shaffer, N C Tolga Emre, et al.
Haematologica|May 7, 2011
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapyTeresa M Cardesa-Salzmann, Luis Colomo, Gonzalo Gutierrez, et al.
Pageof 8